Idorsia
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Hegenheimermattweg 91, Allschwil, Basel-...Phone Number
+41 588440000Website
www.idorsia.comRevenue
$293.8 MillionStock Symbol
IDIAIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Idorsia
Idorsia Ltd headquartered in Switzerland, Idorsia specializes in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, a research center, and a strong balance sheet.Explore more
Idorsia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Idorsia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Idorsia, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Idorsia launches new products
Funding: Get notified immidiatlly once Idorsia has new funding data
Check if Idorsia has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Idorsia recently announced quarterly report
Click to see if Idorsia had a recent Job posting/layoffs
Check out if Idorsia is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Idorsia
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Idorsia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Idorsia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Idorsia.
Idorsia financials insights
Gather financial insights about Idorsia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$341.7M
Stock Offering
$626.5M
2023
Debt
$83M
Idorsia Tech Stack
A closer look at the technologies used by Idorsia
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Idorsia News & Media
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
Ad hoc announcement pursuant to Art. 53 LRIdorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant regionInvitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
Idorsia will publish its Half Year 2026 Financial Reporting on Thursday July 30, at 07:00 CEST.Idorsia appoints Roland Wandeler as Chief Executive Officer
Ad hoc announcement pursuant to Art. 53 LR
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Idorsia
Sign Up For FreeTo access detailed company insights
Idorsia Ltd headquartered in Switzerland, Idorsia specializes in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, a research center, and a strong balance sheet.... Read More
